Furthermore, this study demonstrated that patients with two inherited pathogenic variants were more likely to develop ovarian cancer compared with those with a BRCA2 pathogenic variant alone (16.9 vs. 9.3%, p = 0.0017) [25]. The gene discussed is BRCA2; the disease is ovarian cancer.